Thrombolytic Therapy for Acute Myocardial Infarction in Actively Menstruating Women

Letters1 November 1993Thrombolytic Therapy for Acute Myocardial Infarction in Actively Menstruating WomenScott H. McCallister, MD, Daniel L. Lips, MD, and Thomas J. Linnemeier, MDScott H. McCallister, MDSearch for more papers by this author, Daniel L. Lips, MDSearch for more papers by this author, and Thomas J. Linnemeier, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-119-9-199311010-00026 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:The use of systemic thrombolytic agents is widely accepted as standard therapy for acute myocardial infarction. A history of active bleeding is appropriately considered a contraindication, and many clinicians equate menstrual bleeding with active bleeding. However, because most clinical trials have excluded women of childbearing age, the use of thrombolytic agents during menstruation has not been clearly defined. We report the successful use of systemic thrombolytic therapy in an actively menstruating woman with acute myocardial infarction.A 43-year-old woman came to the emergency room with a 4-hour history of chest pain, and an electrocardiogram showed evidence of ...References1. Conti CR. Is menstruation a contraindication to thrombolytic therapy? Clin Cardiol. 1992; 15:625-6. Google Scholar2. de Gregorio B, Goldstein J, Haft JI. Administration of intracoronary streptokinase during menstruation. Am Heart J. 1985; 109:908-10. Google Scholar3. Chop WM, Evans PJ, Felty K. Thrombolytic therapy during active menstruation: a case report. J Family Pract. 1991; 33:79-81. Google Scholar4. Donovan BC. How to give thrombolytic therapy safely. Chest. 1989; 95:290S-292S. Google Scholar5. Topol EJ. Thrombolytic therapy in acute MI: safe during menses? J Crit Illness. 1992; 7:14. Google Scholar Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByCan We Provide Reperfusion Therapy to All Unselected Patients Admitted With Acute Myocardial Infarction?Treating menstruating women with thrombolytic therapy: Insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trial 1 November 1993Volume 119, Issue 9Page: 955KeywordsAcute myocardial infarctionCatheterizationClinical trialsCoronary angioplastyElectrocardiographyEmergency departmentHemoglobinHemorrhageResearch laboratoriesSafety Issue Published: 1 November 1993 CopyrightCopyright © 1993 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...